Skip to main content
. 2016 Apr 14;11(4):e0153411. doi: 10.1371/journal.pone.0153411

Table 2. Differential gene expression between MF ILC and adjacent normal tissue.

Gene FC Unadjusted P-value Adjusted P-value qval (FDR) Tumor expression
COL11A1 24.99 1.33E-03 8.97E-01 1.71E-02
PKMYT1 11.66 2.30E-05 1.67E-02 2.79E-03
COMP 9.23 2.35E-03 1.00E+00 2.29E-02
COL1A1 8.40 2.96E-05 2.14E-02 3.08E-03
SIX1 7.93 2.15E-03 1.00E+00 2.20E-02
BMP8A 6.94 2.01E-03 1.00E+00 2.16E-02
ZIC2 5.47 4.55E-03 1.00E+00 3.46E-02
CCNE2 5.05 6.68E-03 1.00E+00 4.47E-02
UBE2T 5.02 2.04E-05 1.48E-02 2.79E-03
MCM2 4.56 2.74E-04 1.93E-01 7.40E-03
COL3A1 4.50 5.76E-05 4.16E-02 4.67E-03
FN1 4.36 2.36E-04 1.67E-01 7.11E-03
CREB3L1 4.30 2.43E-06 1.77E-03 8.87E-04
LEF1 4.19 9.45E-04 6.46E-01 1.47E-02
INHBA 4.14 2.07E-03 1.00E+00 2.19E-02
CDKN2A 4.08 4.68E-03 1.00E+00 3.52E-02
COL5A2 3.92 1.50E-05 1.09E-02 2.73E-03
E2F1 3.68 2.19E-04 1.56E-01 7.11E-03
COL1A2 3.58 4.26E-04 2.97E-01 9.26E-03
GATA3 3.50 2.25E-04 1.59E-01 7.11E-03
COL5A1 3.37 1.58E-04 1.13E-01 6.97E-03
CACNA1D 3.05 2.58E-04 1.82E-01 7.23E-03
IL20RB 3.00 6.78E-04 4.66E-01 1.15E-02
CDKN2B 2.92 6.62E-05 4.78E-02 4.84E-03
CBLC 2.91 3.58E-03 1.00E+00 2.90E-02
HIST1H3H 2.76 1.62E-04 1.16E-01 6.97E-03
BRIP1 2.49 3.04E-03 1.00E+00 2.64E-02
PAX8 2.48 6.26E-03 1.00E+00 4.27E-02
POLE2 2.43 1.08E-05 7.90E-03 2.64E-03
TGFB3 2.41 1.01E-04 7.22E-02 5.00E-03
FEN1 2.38 1.33E-03 8.98E-01 1.71E-02
MAPT 2.32 1.32E-03 8.90E-01 1.71E-02
CCND1 2.28 3.43E-04 2.40E-01 8.35E-03
EZH2 2.18 7.25E-04 4.98E-01 1.19E-02
CREB3L4 2.07 3.17E-03 1.00E+00 2.68E-02
FIGF 0.06 1.50E-03 1.00E+00 1.80E-02
RELN 0.12 4.05E-03 1.00E+00 3.11E-02
PROM1 0.13 1.40E-03 9.44E-01 1.74E-02
SFRP1 0.15 5.02E-03 1.00E+00 3.66E-02
MMP7 0.17 1.52E-03 1.00E+00 1.80E-02
NTRK2 0.22 3.62E-04 2.53E-01 8.52E-03
LAMB3 0.23 2.24E-03 1.00E+00 2.22E-02
SPRY2 0.24 2.13E-04 1.51E-01 7.11E-03
KIT 0.26 2.17E-04 1.54E-01 7.11E-03
CDH1 0.28 4.57E-04 3.17E-01 9.26E-03
IL22RA1 0.29 4.86E-03 1.00E+00 3.59E-02
LIFR 0.29 4.47E-04 3.11E-01 9.26E-03
MET 0.30 5.16E-04 3.57E-01 9.90E-03
EGFR 0.30 2.93E-04 2.06E-01 7.63E-03
FGF10 0.31 1.07E-03 7.31E-01 1.58E-02
ITGB4 0.31 8.07E-05 5.81E-02 5.00E-03
FLNC 0.31 5.65E-03 1.00E+00 3.97E-02
PAK3 0.32 7.08E-03 1.00E+00 4.66E-02
ITGB3 0.35 1.66E-03 1.00E+00 1.90E-02
PDGFRA 0.36 5.60E-04 3.87E-01 1.01E-02
CACNB2 0.37 1.03E-04 7.36E-02 5.00E-03
ITGB8 0.38 1.19E-03 8.05E-01 1.66E-02
ZBTB16 0.38 1.78E-03 1.00E+00 2.00E-02
FZD7 0.38 1.72E-04 1.23E-01 6.99E-03
CREB5 0.41 1.22E-03 8.27E-01 1.68E-02
KLF4 0.41 2.17E-03 1.00E+00 2.20E-02
TCF7L1 0.43 5.59E-04 3.87E-01 1.01E-02
MAML2 0.46 2.43E-04 1.72E-01 7.11E-03
MYC 0.46 5.21E-03 1.00E+00 3.71E-02
PLD1 0.47 4.84E-04 3.36E-01 9.55E-03
GAS1 0.47 6.08E-03 1.00E+00 4.23E-02
ITGB6 0.48 3.36E-04 2.36E-01 8.35E-03
TGFBR2 0.48 6.75E-04 4.65E-01 1.15E-02
CDC14A 0.50 3.32E-03 1.00E+00 2.75E-02

Differential gene expression: ILC tumors versus adjacent normal tissue, FDR<0.05 and FC>2 or <0.5, ordered by direction and fold change. FC = fold change. FDR = false discovery rate.